Skip to content

Isoflurane

General Anesthetic — NERVOUS SYSTEM

Also known as: 1-Chloro-2,2,2-trifluoroethyl difluoromethyl ether, forane, forene, isoforine, isorrane

OfpFDA approvedATC N01AB06

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Isoflurane is an ofp drug in the General Anesthetic class catalogued in DrugCentral. It was first approved by the FDA in 1979. DrugCentral lists 8 molecular targets, including HTR2B, KCNK2 and KCNK3. Recorded indications include General anesthesia.

  • Approval status: ofp (first approved 1979 by the FDA).
  • Drug class: General Anesthetic.
  • Molecular targets: HTR2B, KCNK2, KCNK3 and KCNK9 (8 listed in DrugCentral).
  • Indications: General anesthesia.
  • ATC code: N01AB06 (Halogenated hydrocarbons).
  • Molecular formula: C3H2ClF5O; molecular weight 184.49 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • General anesthesia

Contraindications (5)

  • Disease of liver
  • Duchenne muscular dystrophy
  • Hyperkalemia
  • Low blood pressure
  • Malignant hyperthermia

Mechanism & targets

Established pharmacologic classGeneral Anesthetic

Molecular targets (8)

TargetGeneActionActivity
5-hydroxytryptamine receptor 2BHTR2BunknownKi 5.11
Potassium channel subfamily K member 2KCNK2opener—
Potassium channel subfamily K member 3KCNK3opener—
Potassium channel subfamily K member 9KCNK9opener—
Potassium channel subfamily K member 10KCNK10opener—
Potassium channel subfamily K member 18KCNK18opener—
Glycine receptor (alpha-1/beta)GLRA1|GLRBother—
GABA-A receptor; anion channelGABRP|GABRD|GABRA1|GABRB1|GABRG2|GABRB3|GABRA5|GABRA3|GABRA2|GABRB2|GABRA4|GABRE|GABRA6|GABRG1|GABRG3|GABRQpositive allosteric modulator—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1979-12-18FDA—BAXTER HLTHCARE

ATC classification

ATC codeTherapeutic hierarchy
N01AB06NERVOUS SYSTEM › ANESTHETICS › ANESTHETICS, GENERAL › Halogenated hydrocarbons

Pharmacogenomics

Drug-label and guideline annotations from PharmGKB and CPIC.

  • EMA label
  • FDA label: CACNA1S, RYR1 · Actionable PGx
  • HCSC label: CACNA1S, RYR1 · Actionable PGx

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Hyperthermia malignant546.6
Apnoea230.4
Necrosis ischaemic230.1
Intestinal ischaemia227.2
Post procedural complication211.1
Hypotension206.0
Mitochondrial DNA mutation180.9
Systemic inflammatory response syndrome180.2
Propofol infusion syndrome159.2
Intra-abdominal pressure increased150.3
Blood lactic acid increased137.8
Metabolic acidosis137.8

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Isoflurane is on its molecule page.

Molecular formulaC3H2ClF5O
Molecular weight184.49 g/mol
CAS number26675-46-7
InChIKeyPIWKPBJCKXDKJR-UHFFFAOYSA-N
PubChem CID3763
FC(F)OC(Cl)C(F)(F)F

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Isoflurane used for?

DrugCentral lists the following indications for Isoflurane: General anesthesia.

How does Isoflurane work?

Its molecular targets in DrugCentral include HTR2B, KCNK2 (opener), KCNK3 (opener) and KCNK9 (opener).

When was Isoflurane first approved?

Isoflurane was first approved by the FDA in 1979.

What drug class does Isoflurane belong to?

Isoflurane is in the General Anesthetic class.

What is the chemical formula of Isoflurane?

Isoflurane has the molecular formula C3H2ClF5O and a molecular weight of 184.49 g/mol.

Browse: all drugs starting with I · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1979-12-18
AgencyFDA
Targets8
Indications1
FormulaC3H2ClF5O
DrugCentral ID1493
Interactive profile